Prophylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AML
Sign Up to like & getrecommendations! Published in 2024 at "Blood Advances"
DOI: 10.1182/bloodadvances.2023012120
Abstract: Key Points • Maintenance treatment was safe, with low rates of infections and chronic GVHD, and minimal impact on T-cell immune reconstitution.• With 2-year follow-up, Ven/Aza maintenance showed a manageable safety profile and encouraging responses… read more here.
Keywords: maintenance; high risk; mds aml; prophylactic maintenance ... See more keywords